Hubei Vanz Pharm Co.,ltd.

 

warrantable quality,trustable service!

Home
Products
About Us
Factory Tour
Quality Control
Contact Us
Request A Quote
News
Home ProductsPharmaceutical Raw Materials

Velpatasvir Pharmaceutical Raw Materials Active Pharmaceutical Ingredients

I'm Online Chat Now
China Wuhan Vanz Pharm Inc. certification
China Wuhan Vanz Pharm Inc. certification
I am very happy to cooperate with your company for nearly three years, thank you very attentive service, thank you for the excellent product quality.

—— Stephnie

You always have very fast delivery, very happy to cooperate with you. Thank you.

—— John

Very pleased to become your customer, and very happy for our cooperation, hope to be your long-term parter.

—— Sara

we received the package, very fast, the quality is very good, will continue to buy your products.

—— Luice

I have emailed you a couple times and they get returned as undeliverable. Yes. I am happy with the powders. thank you.

—— Bryan

Velpatasvir Pharmaceutical Raw Materials Active Pharmaceutical Ingredients

Velpatasvir Pharmaceutical Raw Materials Active Pharmaceutical Ingredients
Velpatasvir Pharmaceutical Raw Materials Active Pharmaceutical Ingredients Velpatasvir Pharmaceutical Raw Materials Active Pharmaceutical Ingredients

Large Image :  Velpatasvir Pharmaceutical Raw Materials Active Pharmaceutical Ingredients Get Best Price

Product Details:

Place of Origin: china (mainland)
Brand Name: vanz
Certification: coa
Model Number: medicine grade

Payment & Shipping Terms:

Packaging Details: in aluminium or depand on client requirements
Delivery Time: 3days after paid
Payment Terms: T/T, Western Union, MoneyGram
Detailed Product Description
Molecular Weight: 883.01 Molecular Formular: C49H54N8O8
Quality Standard: Enterprise Standard CAS#: 1377049-84-7
Density: 1.3 Purity: 99%
High Light:

medicine raw material

,

raw pharmaceutical materials

Velpatasvir Pharmaceutical Raw Materials Active Pharmaceutical Ingredients

 

Product details:

 

Treat all six main HCV genotypes in the first scheme, velpatasvir, a new drug, and was the first to treat all six main type of HCV.
 

The FDA's drug evaluation and research center director of antimicrobial products in said: "the approval for a broad range of patients with chronic hepatitis c provides a treatment and treatment options."Priority review.

 

velpatasvir, an investigational pan-genotypic NS5A inhibitor, for the treatment of chronic genotype 1-6 hepatitis C virus (HCV) infection.

 

In phase 2 trials, treatment with the combination of the nucleotide polymerase inhibitor sofosbuvir and the NS5A inhibitor velpatasvir resulted in high rates of sustained virologic response in patients chronically infected with hepatitis C virus (HCV) genotype 2 or 3.

 

Sofosbuvir works by interfering with the activity of an enzyme (NS5B) used by HCV-infected cells. Velpatasvir works by interfering with another HCV enzyme called NS5A.

 

Results:

 

Overall, 99% of participants who took sofosbuvir + velpatasvir were cured of hepatitis C 12 weeks after the cessation of therapy. Such high cure rates occurred regardless of the genotype or subtype of HCV. This cure, referred to as a sustained virological response, is written as SVR12. None of the participants who received placebo were cured.

 

 

Specifications:

 

Product name Velpatasvir
CAS NO. 1377049-84-7
Synonyms Velpatasvir
Category Pharmaceutical Raw Materials,Active Pharmaceutical Ingredients,Bulk Drugs,Fine Chemicals.
Standard purity:>99%
Appearance Velpatasvir powder
Shelf life 2 years
Usage Velpatasvir is used for treat Hepatitis C virus.
Storage Velpatasvir should be stored in a well-closed container at low temperature, keep away from moisture, heat and light.

 

Chemical structure :

 

 

 

Velpatasvir Pharmaceutical Raw Materials Active Pharmaceutical Ingredients 0

 

 

Contact Details
Wuhan Vanz Pharm Inc.

Contact Person: Ms. du

Tel: 86 13277095342

Fax: 86-27-84492310

Send your inquiry directly to us